We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




SARS Virus May Be a Hybrid

By Biotechdaily staff writers
Posted on 30 Dec 2003
Researchers have found that the coronavirus that causes severe acute respiratory syndrome (SARS) is formed from genetic material that may have resulted from the combination of mammalian and avian viruses. More...


Investigators at the University of Toronto (Canada) used Bayesian, neighbor-joining, and split decomposition phylogenetic techniques on the SARS virus replicase, surface spike, matrix, and nucleocapsid proteins to examine the evolutionary origin of the SARS coronavirus.

They reported in the January 2004 issue of the Journal of Virology that the replicase protein was of mammalian-like origin, the matrix and nucleocapsid proteins were of avian-like origin, and the host-determining spike protein was of a mammalian-avian mosaic origin.

It is believed the virus was transmitted to humans by masked palm civets (an animal related to ferrets and cats) in the food markets of southern China. "It is possible that a civet picked up the virus from a bird,” explained senior author Dr. David Guttman, professor of evolutionary genomics at the University of Toronto. "This could have created the opportunity for a very rare recombination event that produced a virus with a new host range. These recombination events have the potential to create an entirely new structure essentially instantaneously. Since our immune systems have never seen this new viral form, it is more difficult for them to respond to it in a timely and effective manner.”



Related Links:
University of Toronto

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Automated Urinalysis Solution
UN-9000
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.